Non-alcoholic fatty liver infiltration in children: an underdiagnosed evolving disease

Flora Tzifi; Andreas Fretzayas; George Chrousos; Christina Kanaka‐Gantenbein

doi:10.1007/s42000-019-00107-7

Related publications

Article2018

Parental non‐alcoholic fatty liver disease increases risk of non‐alcoholic fatty liver disease in offspring

Michelle T. Long, Ellen B. Gurary, Joseph M. Massaro, Jiantao Ma, Udo Hoffmann, Raymond T. Chung, Emelia Benjamin, Rohit Loomba

Article2021

Non-alcoholic fatty liver disease (NAFLD)/non-alcoholic steatohepatitis (NASH)-related liver fibrosis: mechanisms, treatment and prevention

Frank Tacke, Ralf Weiskirchen

Article2022

Lactational delivery of Triclosan promotes non-alcoholic fatty liver disease in newborn mice

André Alberto Weber, Xiaojing Yang, Elvira Mennillo, Jeffrey Ding, Jeramie D. Watrous, Mohit Jain, Shujuan Chen, Michael Karin, Robert H. Tukey

Preprint2022

Lactational delivery of Triclosan promotes non-alcoholic fatty liver disease in newborn mice

André Alberto Weber, Xiaojing Yang, Elvira Mennillo, Jeffrey Ding, Jeramie D. Watrous, Mohit Jain, Shujuan Chen, Michael Karin, Robert H. Tukey

Article2018

Caffeine-stimulated muscle IL-6 mediates alleviation of non-alcoholic fatty liver disease

Chongye Fang, Xianbin Cai, Shuhei Hayashi, Shumei Hao, Haruhiko Sakiyama, Xuanjun Wang, Qin Yang, Akira Shizuo, Shuhei Nishiguchi, Noriko Fujiwara, Hiroko Tsutsui, Jun Sheng

Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids

Non-alcoholic fatty liver infiltration in children: an underdiagnosed evolving disease

Discussion(0)

Related publications

Parental non‐alcoholic fatty liver disease increases risk of non‐alcoholic fatty liver disease in offspring

Non-alcoholic fatty liver disease (NAFLD)/non-alcoholic steatohepatitis (NASH)-related liver fibrosis: mechanisms, treatment and prevention

Lactational delivery of Triclosan promotes non-alcoholic fatty liver disease in newborn mice

Lactational delivery of Triclosan promotes non-alcoholic fatty liver disease in newborn mice

Caffeine-stimulated muscle IL-6 mediates alleviation of non-alcoholic fatty liver disease